VKTX - Viking Therapeutics Inc
IEX Last Trade
64.14
1.490 2.323%
Share volume: 2,760,490
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$62.65
1.49
2.38%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.18%
Return on assets
-11.96%
Return on sales
0%
Return on invested capital
110.6%
Total debt ratio
18.88%
Debt ratio change over timeo
-0.75%
Current Ratio
30.1%
Quick Ratio
0%
Cash Position Ratio
4.73%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.4%
Return on assets
-3.68%
Return on sales
0%
Return on invested capital
115.06%
Total debt ratio
3.21%
Debt ratio change over timeo
-0.97%
Current Ratio
32.79%
Quick Ratio
0%
Cash Position Ratio
1.37%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-3.66%
Return on assets
-3.73%
Return on sales
0%
Return on invested capital
100.67%
Total debt ratio
3.73%
Debt ratio change over time
-0.97%
Current Ratio
27.09%
Quick Ratio
0%
Cash Position Ratio
0.4%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-144.36%
Return on assets
-115.04%
Return on sales
0%
Return on invested capital
16.53%
Total debt ratio
-75.4%
Debt ratio change over time
-0.75%
Current Ratio
25.35%
Quick Ratio
0%
Cash Position Ratio
3.3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VKTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -33.18% | -3.65% | 12.3% | 6.42% |
| Return on assets | -11.96% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 110.6% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 69% | 61% |
| Total debt ratio | 18.88% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.75% | 224.03% | 6.03% | 1.46% |
| Dept financing | 5% | 50% | 19% | 8% |
| Current Ratio | 32.79% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.37% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 15% | 31% | 34% |
| Short-term ratios | VKTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.4% | -16.17% | 18.05% | 7.63% |
| Return on assets | -3.68% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 115.06% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 36% | 69% | 64% |
| Total debt ratio | 3.21% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.97% | 851.68% | 10.97% | 0.58% |
| Dept financing | 1% | 50% | 21% | 8% |
| Current Ratio | 32.79% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.37% | 1.41% | 0.73% | 1.41% |
| Liquididy | 49% | 43% | 28% | 53% |